Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision label (v3.6.4) replacing the previous (v3.6.3), indicating a background deployment update. No substantive study information or UI content appears to be altered.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, signaling a new published update to the study record. The underlying study data remains unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2. This reflects a software/documentation update rather than changes to trial content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now indicates that recruitment has ended for this study. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes a minor label formatting change for Intervention/Treatment.SummaryDifference0.4%

- Check61 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a new deployment of the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer version of the page has been published.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.